Olmesartan for the prevention or delay of diabetic nephropathy: some considerations
Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):678-9; author reply 679-80.
doi: 10.1016/j.recesp.2012.03.006.
Epub 2012 May 17.
[Article in
English,
Spanish]
No abstract available
MeSH terms
-
Albuminuria / drug therapy*
-
Angiotensin II Type 1 Receptor Blockers / adverse effects*
-
Angiotensin II Type 1 Receptor Blockers / therapeutic use*
-
Diabetes Mellitus, Type 2 / mortality*
-
Diabetic Cardiomyopathies / drug therapy*
-
Female
-
Humans
-
Imidazoles / adverse effects*
-
Imidazoles / therapeutic use*
-
Male
-
Tetrazoles / adverse effects*
-
Tetrazoles / therapeutic use*
Substances
-
Angiotensin II Type 1 Receptor Blockers
-
Imidazoles
-
Tetrazoles